<?xml version="1.0" encoding="UTF-8"?>
<p id="p0010">In December 2019, the Chinese health authorities reported the emergence of a novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in Wuhan (China), after clinicians had published that this new Sarbecovirus was causing a disease subsequently named COVID-19 (coronavirus disease 2019) [
 <xref rid="bib1" ref-type="bibr">1</xref>,
 <xref rid="bib2" ref-type="bibr">2</xref>]. In fact, retrospective studies show that SARS-CoV-2 has already been circulating for several weeks, probably since October 2019, with a case of COVID-19 formally identified on 17 November 2019 [
 <xref rid="bib3" ref-type="bibr">3</xref>]. Among 10Â 237 infected individuals with SARS-CoV-2 included in a nationwide cohort in South Korea (24 January to 9 April 2020), 6350 individuals (62%) were asymptomatic [
 <xref rid="bib4" ref-type="bibr">4</xref>]. In another study on 1096 individuals in Kuwait (24 February to 20 April 2020), 46.3% of the infected people were asymptomatic on the sample day [
 <xref rid="bib5" ref-type="bibr">5</xref>]. Thirty-five individuals (6.9%) who were initially asymptomatic developed symptoms later [
 <xref rid="bib5" ref-type="bibr">5</xref>]. Asymptomatic infection can occur at any age, but had a higher prevalence in patients under 45 years old compared with symptomatic people [
 <xref rid="bib6" ref-type="bibr">6</xref>]. In a meta-analysis, the most frequent clinical signs and symptoms reported in symptomatic patients were fever (78.5%), cough (53.8%) and fatigue (25.0%), and 6.8% of the patients were admitted to the intensive care unit and 7.7% died during hospitalization due to complications related to COVID-19 (pneumonia, secondary bacterial infection and respiratory failure) [
 <xref rid="bib7" ref-type="bibr">7</xref>].
</p>
